Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
2011 StandoutScience
Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
2013
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer
2011
Deciphering O -glycoprotease substrate preferences with O-Pair Search
2022 StandoutNobel
Chromatin modifiers and the promise of epigenetic therapy in acute leukemia
2014
Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
2020
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
Targeting the E3 ubiquitin ligases DCAF15 and cereblon for cancer therapy
2020
Priming virulence factors for delivery into the host
2003
Molecular and Cellular Mechanisms of Salmonella Pathogenesis
1994
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
2018
Cell Sensitivity Assays: The MTT Assay
2011 Standout
Gut biogeography of the bacterial microbiota
2015 Standout
Alternatives to antibiotics: chemical and physical antimicrobial interventions and foodborne pathogen response
2005
TGF-β: the master regulator of fibrosis
2016 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Contact with epithelial cells induces the formation of surface appendages on Salmonella typhimurium
1994
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Transcriptional activation of Salmonella typhimurium invasion genes by a member of the phosphorylated response‐regulator superfamily
1996
50-plus years of fungal viruses
2015 Standout
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
2010
Advances in DNA methylation: 5-hydroxymethylcytosine revisited
2011
Brentuximab vedotin
2012
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Breaking the chains: structure and function of the deubiquitinases
2009 Standout
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Revealing the human mucinome
2022 StandoutNobel
Epigenetic cancer therapy: rationales, targets and drugs
2011
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
2019
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
A generic protein purification method for protein complex characterization and proteome exploration
1999 Standout
Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
2020
Oxidative Stress in Cancer
2020 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Hallmarks of Cellular Senescence
2018 Standout
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Therapy with azanucleosides for myelodysplastic syndromes
2010
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
2021
The future of epigenetic therapy in solid tumours—lessons from the past
2013
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Glycoproteomics
2022 StandoutNobel
Research on the Human Proteome Reaches a Major Milestone: >90% of Predicted Human Proteins Now Credibly Detected, According to the HUPO Human Proteome Project
2020
Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis
1995
Relative Structural and Functional Roles of Multiple Deubiquitylating Proteins Associated with Mammalian 26S Proteasome
2007
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
Recent developments in myelodysplastic syndromes
2014
Double-stranded RNA viruses of Saccharomyces cerevisiae
1996
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase
1995
Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
2008
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
2021 Standout
cag , a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
1996 Standout
New Ways to Use DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndrome
2011
Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings
2016
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Essential oils as antimicrobials in food systems – A review
2015 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Common themes in microbial pathogenicity revisited
1997 Standout
Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds
2015
Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils.
1993
Combination therapy in combating cancer
2017 Standout
Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
2009
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells
2008
Expression of the Totivirus Helminthosporium victoriae 190S Virus RNA-Dependent RNA Polymerase from Its Downstream Open Reading Frame in Dicistronic Constructs
2000
Natural product and natural product derived drugs in clinical trials
2014 Standout
Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants
1998 Standout
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Contact with cultured epithelial cells stimulates secretion of Salmonella typhimurium invasion protein InvJ
1995
The Ubiquitin Code
2012 Standout
Yersinia pestis--etiologic agent of plague
1997 Standout
Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion
2004 Standout
Interaction of Listeria monocytogenes with mouse dendritic cells
1995
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure
2016
Alternate routes of invasion may affect pathogenesis of Salmonella typhimurium in swine
1995
Drug Resistance in Cancer: An Overview
2014 Standout
Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice
2018
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Works of Kyle J. MacBeth being referenced
The class‐I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6‐independent mechanism
2010
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
2010
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
2014
A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes
2016
Abstract 4956: Functional characterization of the ivosidenib (AG-120) and azacitidine combination in a mutant IDH1 AML cell model
2018
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Patients with Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML).
2009
The short transcript of Leishmania RNA virus is generated by RNA cleavage
1995
Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome
2018
The JAMM motif of human deubiquitinase Poh1 is essential for cell viability
2007
Mutant IDH (mIDH) inhibitors, ivosidenib or enasidenib, with azacitidine (AZA) in patients with acute myeloid leukemia (AML).
2018
Prolonged inhibition of bacterial protein synthesis abolishes Salmonella invasion
1993
Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
2011